Single-incision slings for the treatment of stress urinary incontinence: efficacy and adverse effects at 10-year follow-up.

Complications Functional outcomes Long-term follow-up Quality of life Single-incision sling Stress urinary incontinence

Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 30 06 2020
accepted: 13 08 2020
pubmed: 10 9 2020
medline: 24 6 2021
entrez: 9 9 2020
Statut: ppublish

Résumé

Single-incision slings are not considered a first-choice surgical treatment owing to a lack of data about long-term outcomes. We aimed to assess the long-term results of urinary incontinence treatment after single-incision sling implantation at 10 years' follow-up and to investigate possible deterioration over time. This retrospective study analyzed women with subjective and urodynamically proven stress urinary incontinence who underwent single-incision sling procedure. The objective cure rate was assessed with a 300-ml stress test. The subjective cure rate was determined by the Patient Global Impression of Improvement (PGI-I) questionnaire. International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) questionnaire scores and self-answered patient-satisfaction scales were collected to assess symptom severity. Findings were compared with short-term outcomes in the same patients, available through our previous database, in order to detect possible outcome deterioration over time. The records of 60 patients were analyzed. Nine patients (15%) were lost to follow-up. A total of 51 patients completed the evaluation, with a mean follow-up of 10.3 ± 0.7 years. Objective and subjective cure resulted 86.3% and 88.2% respectively. Mean PGI-I scores and ICIQ-SF were 1.5 ± 1.0 and 3.2 ± 4.8 respectively. Patients' satisfaction scored 8.6 ± 2.6 out of 10. No long-term complications occurred. Comparison of short-term (2.6 ± 1.4 years after surgery) and long-term follow-up did not show a significant deterioration of outcome over time. Single-incision slings were shown to be a procedure with a great efficacy and safety profile at very long-term follow-up. Cure rates and functional outcomes did not show any deterioration over time compared with short-term results.

Identifiants

pubmed: 32902762
doi: 10.1007/s00192-020-04499-8
pii: 10.1007/s00192-020-04499-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-191

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

Bo K, Frawley HC, Haylen BT, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and nonpharmacological management of female pelvic floor dysfunction. Neurourol Urodyn. 2017;36:221–44.
doi: 10.1002/nau.23107
Ford AA, Rogerson L, Cody JD, Ogah J. Midurethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2015;(7):CD006375. https://doi.org/10.1002/14651858.CD006375.pub3 .
Aydın S, Arıoğlu Aydın Ç. Effect of concomitant single incision vaginal surgery on mid urethral sling success. Neurourol Urodyn. 2016;35(8):995–9.
doi: 10.1002/nau.22847
Rovner ES, Wein AJ. Treatment options for stress urinary incontinence. Rev Urol. 2004;6(Suppl 3):S29–47.
pubmed: 16985862 pmcid: 1472859
Cox A, Herschorn S, Lee L. Surgical management of female SUI: is there a gold standard? [published correction appears in Nat Rev Urol. 2013;10(4):188]. Nat Rev Urol. 2013;10(2):78–89. https://doi.org/10.1038/nrurol.2012.243 .
doi: 10.1038/nrurol.2012.243 pubmed: 23318365
Ulmsten U, Petros P. Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scand J Urol Nephrol. 1995;29(1):75–82.
doi: 10.3109/00365599509180543
Geller EJ, Wu JM. Changing trends in surgery for stress urinary incontinence. Curr Opin Obstet Gynecol. 2013;25(5):404–9. https://doi.org/10.1097/GCO.0b013e3283648cdd .
doi: 10.1097/GCO.0b013e3283648cdd pubmed: 23872710
Barber MD, Kleeman S, Karram MM, et al. Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2008;111(3):611–21.
doi: 10.1097/AOG.0b013e318162f22e
Milani R, Manodoro S, Cola A, Palmieri S, Frigerio M. Management of unrecognized bladder perforation following suburethral tape procedure. Int J Gynaecol Obstet. 2018;142(1):118–9.
doi: 10.1002/ijgo.12493
Delorme E. [Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women]. Prog Urol. 2001;11(6):1306–13.
pubmed: 11859672
Bianchi-Ferraro AM, Jarmy-DiBella ZI, De Aquino Castro R, et al. Randomized controlled trial comparing TVT-O and TVT-S for the treatment of stress urinary incontinence: 2-year results. Int Urogynecol J. 2014;25:1343–8.
doi: 10.1007/s00192-014-2352-7
Martan A, Masata J, Svabík K. [TVT SECUR system—tension-free support of the urethra in women suffering from stress urinary incontinence—technique and initial experience]. Ceska Gynekol. 2007;72(1):42–9.
pubmed: 17357349
Mostafa A, Lim CP, Hopper L, Madhuvrata P, Abdel-Fattah M. Single-incision mini-slings versus standard midurethral slings in surgical management of female stress urinary incontinence: an updated systematic review and meta-analysis of effectiveness and complications. Eur Urol. 2014;65(2):402–27.
doi: 10.1016/j.eururo.2013.08.032
Spelzini F, Frigerio M, Regini C, Palmieri S, Manodoro S, Milani R. Learning curve for the single-incision suburethral sling procedure for female stress urinary incontinence. Int J Gynaecol Obstet. 2017;139(3):363–7.
doi: 10.1002/ijgo.12317
Palmieri S, Frigerio M, Spelzini F, Manodoro S, Milani R. Risk factors for stress urinary incontinence recurrence after single-incision sling. Neurourol Urodyn. 2018;37(5):1711–6.
doi: 10.1002/nau.23487
Frigerio M, Regini C, Manodoro S, Spelzini F, Milani R. Mini-sling efficacy in obese versus non-obese patients for treatment of stress urinary incontinence. Minerva Ginecol. 2017;69(6):533–7.
pubmed: 28598139
Spelzini F, Cesana MC, Verri D, Polizzi S, Frigerio M, Milani R. Three-dimensional ultrasound assessment and middle term efficacy of a single-incision sling. Int Urogynecol J. 2013;24(8):1391–7.
doi: 10.1007/s00192-012-2031-5
Leone Roberti Maggiore U, Finazzi Agrò E, Soligo M, Li Marzi V, Digesu A, Serati M. Long-term outcomes of TOT and TVT procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2017;28(8):1119–30.
doi: 10.1007/s00192-017-3275-x
Manodoro S, Spelzini F, Frigerio M, Nicoli E, Verri D, Milani R. Is occult stress urinary incontinence a reliable predictive marker? Female Pelvic Med Reconstr Surg. 2016;22(4):280–2.
doi: 10.1097/SPV.0000000000000272
Schäfer W, Abrams P, Liao L, et al. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn. 2002;21(3):261–74.
doi: 10.1002/nau.10066
Tubaro A, Zattoni F, Prezioso D, et al. Italian validation of the international consultation on incontinence questionnaires. BJU Int. 2006;97(1):101–8.
doi: 10.1111/j.1464-410X.2006.05885.x
Spelzini F, Manodoro S, Cola A, Palmieri S, Roselli F, Frigerio M. Single-incision sling for stress urinary incontinence: a video tutorial. Eur J Obstet Gynecol Reprod Biol. 2019;237:216–7.
doi: 10.1016/j.ejogrb.2019.04.037
Srikrishna S, Robinson D, Cardozo L. Validation of the patient global impression of improvement (PGI-I) for urogenital prolapse. Int Urogynecol J. 2010;21(5):523–8.
doi: 10.1007/s00192-009-1069-5
Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5–26.
doi: 10.1007/s00192-009-0976-9
Lo TS, Chua S, Tan YL, Patrimonio MC, Pue LB. Ultrasonography and clinical outcomes following anti-incontinence procedures (Monarc vs MiniArc): a 3-year post-operative review. PLoS One. 2018;13(12):e0207375. https://doi.org/10.1371/journal.pone.0207375 .
doi: 10.1371/journal.pone.0207375 pubmed: 30513097 pmcid: 6279016
Lo TS, Chua S, Kao CC, Uy-Patrimonio MC, Ibrahim R, Tan YL. Five-year outcome of MiniArc single-incision sling used in the treatment of primary urodynamic stress incontinence. J Minim Invasive Gynecol. 2018;25(1):116–23. https://doi.org/10.1016/j.jmig.2017.08.647 .
doi: 10.1016/j.jmig.2017.08.647 pubmed: 28826955
Sun Z, Wang X, Lang J, et al. Comparison of outcomes between single-incision sling and transobturator sling for treating stress urinary incontinence: a 10-year prospective study. Neurourol Urodyn. 2019;38(7):1852–8.
doi: 10.1002/nau.24078
Lucas MG, Bedretdinova D, Bosch JLHR, et al. European Association of Urology (EAU) guidelines. Guidelines on urinary incontinence. 2015. https://uroweb.org/wp-content/uploads/EAU-Guidelines-Urinary-Incontinence-2015.pdf
Cornu JN, Lizée D, Sèbe P, et al. TVT SECUR single-incision sling after 5 years of follow-up: the promises made and the promises broken. Eur Urol. 2012;62(4):737–8.
doi: 10.1016/j.eururo.2012.06.054
Mira Gon L, Zanettini Riccetto CL, Citatini de Campos CC, Iamashita Voris BR, Reis LO, Rodrigues Palma PC. Mini-sling Ophira at 8 years follow-up: does it sustain results? Urol Int. 2019;102(3):326–30.
doi: 10.1159/000496560
Update on the Independent Medicines and Medical Devices Safety Review: written statement—HCWS841. Published July 2018.
Ford AA, Rogerson L, Cody JD, Aluko P, Ogah JA. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017; 7(7):CD006375.
pubmed: 28756647
Seklehner S, Laudano MA, Xie D, Chughtai B, Lee RK. A metaanalysis of the performance of retropubic mid urethral slings versus transobturator mid urethral slings. J Urol. 2015;193:909–15.
doi: 10.1016/j.juro.2014.09.104
ACQSHC. Care pathway for the management of Stress Urinary Incontinence 2018.
Haylen BT, Lee JKS, Sivagnanam V, Cross A. What if there were no tapes? Neurourol Urodyn. 2018;37(6):2026–34.
doi: 10.1002/nau.23741

Auteurs

Matteo Frigerio (M)

ASST Monza, San Gerardo Hospital, Monza, Italy.

Rodolfo Milani (R)

ASST Monza, San Gerardo Hospital, Monza, Italy.

Marta Barba (M)

University of Milano-Bicocca, Monza, Italy.

Luca Locatelli (L)

University of Milano-Bicocca, Monza, Italy.

Giuseppe Marino (G)

University of Milano-Bicocca, Monza, Italy.

Gianluca Donatiello (G)

University of Milano-Bicocca, Monza, Italy.

Federico Spelzini (F)

AUSL Romagna, Infermi Hospital, Rimini, Italy.

Stefano Manodoro (S)

ASST Santi Paolo e Carlo, Ospedale San Paolo, via Antonio di Rudini, Milan, Italy. stefano.manodoro@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH